Hip Dysplasia Clinical Trials

15 recruitingLast updated: June 18, 2026

There are 15 actively recruiting hip dysplasia clinical trials across 10 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 3. Top locations include Vancouver, British Columbia, Canada, St Louis, Missouri, United States, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


Hip Dysplasia Trials at a Glance

15 actively recruiting trials for hip dysplasia are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Vancouver, St Louis, and Chicago. Lead sponsors running hip dysplasia studies include University of British Columbia, Medacta International SA, and Maidstone & Tunbridge Wells NHS Trust.

Browse hip dysplasia trials by phase

Treatments under study

About Hip Dysplasia Clinical Trials

Looking for clinical trials for Hip Dysplasia? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hip Dysplasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hip Dysplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Not Applicable

EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))

Rheumatoid ArthritisOsteoarthritisTraumatic Arthritis+3 more
DePuy Orthopaedics118 enrolled5 locationsNCT06631638
Recruiting
Not Applicable

Exercise and Patient Education Compared With Usual Care in Patients With Hip Dysplasia

Hip Dysplasia
University of Aarhus200 enrolled2 locationsNCT04795843
Recruiting
Phase 2Phase 3

Can PLIA Reduce Early Post-operative Pain After PAO Surgery?

Hip Dysplasia
Michael C Willey120 enrolled1 locationNCT06519955
Recruiting
Not Applicable

Pavlik Harness Treatment vs Monitoring for Treatment of Developmental Dysplasia of the Hip (DDH) in Babies Diagnosed With Graf Type 2 Hips

Developmental Hip Dysplasia
Maidstone & Tunbridge Wells NHS Trust70 enrolled1 locationNCT07111858
Recruiting
Not Applicable

Early Feasibility Study of Cartilage Defect Repair

(Femoroacetabular Impingement)Hip DysplasiaOsteonecrosis+3 more
Cytex Therapeutics, Inc.15 enrolled1 locationNCT06823089
Recruiting
Not Applicable

Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

Hip Dysplasia
Ottawa Hospital Research Institute204 enrolled7 locationsNCT03481010
Recruiting
Not Applicable

Developmental Dysplasia of the Hip: Observation vs. Bracing

Hip DysplasiaDevelopmental Dysplasia of the HipHip Dysplasia, Congenital+1 more
University of British Columbia514 enrolled1 locationNCT05869851
Recruiting

Pediatric Orthopaedic Implant Safety & Efficacy

Pediatric ALLFractureLengthening; Leg+8 more
University of British Columbia4,000 enrolled1 locationNCT05361980
Recruiting
Not Applicable

Shelf Acetabuloplasty With 3D Printed Implants as a New Treatment for Symptomatic Adult Hip Dysplasia

Hip Dysplasia
Replasia BV10 enrolled1 locationNCT07072832
Recruiting

The Medacta International SMS Post-Marketing Surveillance Study

Traumatic ArthritisAvascular Necrosis of the Femoral HeadArthrosis+2 more
Medacta International SA550 enrolled4 locationsNCT02748408
Recruiting

Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System

Hip Dysplasia, CongenitalArthritis Hip
Medacta International SA150 enrolled1 locationNCT06775704
Recruiting
Not Applicable

Clinical Trial of Concomitant Hip Arthroscopy During PAO

Hip Dysplasia
Mayo Clinic106 enrolled1 locationNCT03181048
Recruiting
Phase 4

PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery

Hip DysplasiaHip DiseaseHip Arthropathy
Poznan University of Medical Sciences60 enrolled1 locationNCT07023094
Recruiting

Global Hip Dysplasia Registry

Congenital Hip DysplasiaHip Dislocation, CongenitalHip Dysplasia, Congenital, Nonsyndromic+9 more
University of British Columbia5,000 enrolled1 locationNCT04117685
Recruiting
Phase 4

Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy

Pain, PostoperativeCerebral PalsyHip Dysplasia
University of California, Los Angeles90 enrolled4 locationsNCT06189781